Objective Τo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …

Data regarding COVID-19 vaccine efficacy and adverse events (AE) in patients with
autoimmune and inflammatory rheumatic diseases (AIIRD) have been published recently …

Abstract The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of
unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as …

The severe acute respiratory syndrome coronavirus 2-induced coronavirus disease 2019
(COVID-19) has had a global spread. Vaccines play an essential role in preventing the …

Vaccination is an important and effective tool to prevent infections in the general population,
as well as in patients with autoimmune and inflammatory rheumatic diseases. It has been …

As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination
has been considered an effective measure to protect people from the COVID-19 and end the …

Introduction Emerging evidence supports the immunogenic response to mRNA COVID-19
vaccine in patients with autoimmune rheumatic diseases (ARD). However, large-scale data …

Objectives To assess antibody and T cell responses to SARS-CoV-2 vaccination in patients
with rheumatoid arthritis (RA) on disease-modifying antirheumatic drugs (DMARDs) …

Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …